Background: Scrub typhus is an acute febrile disease for which synthetic tetracycline antibiotics are efficacious. However, no clinical studies have compared oral doxycycline with intravenous minocycline for treatment of scrub typhus. Methods: We conducted a retrospective analysis in patients diagnosed with noncomplicated scrub typhus by serologic or molecular methods from August 2001 to July 2007. We compared the efficacy of intravenous minocycline with oral doxycycline for treatment of noncomplicated scrub typhus in these patients. Results: Forty seven cases receiving tetracycline antibiotics for the treatment of noncomplicated scrub typhus were included. There was no statistically significant difference for the response rate between the 25 cases receiving intravenous minocycline (96%) and the 22 cases receiving oral doxycycline (91%) (p Z 0.909). Kaplan-Meier curve with a long-rank test for the time to defervescence showed no statistically significant difference between minocycline therapy (mean 30 hours; range 4e124 hours) and doxycycline therapy (mean 32.4 hours; range 4e144 hours) (p Z 0.860). After multivariate Cox regression models, the time to defervescence was only affected by Acute Physiology and Chronic Health Evaluation II score (hazard ratio 0.868; p Z 0.016). Nearly all patients (93.6%) became afebrile within 72 hours after use of tetracycline antibiotics. Prolonged hospitalization (> 7 days) was correlated with the timing to start tetracycline antibiotics after admission. Conclusion: Both antibiotics have similar efficacy for the treatment of noncomplicated scrub typhus. Nearly all cases responding to both antibiotics became afebrile within 3 days.
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Introduction
Scrub typhus is an acute febrile human disease caused by Orientia tsutsugamushi that is transmitted to human by the bite of an infected chigger. It is a common zoonotic disease of rural Asia and western Pacific islands. 1 In Taiwan, the annual number of confirmed cases has increased from 39 cases in 1990 to 462 in 2005 2 because of the improvement of diagnostic facilities, especially in eastern Taiwan where our hospital is located. Clinical manifestations vary from mild fever to multiple organ failure. 3, 4 Tetracycline compounds have been used for treatment worldwide since their commercial introduction in 1953. The development of synthetic antibiotics began with doxycycline in 1967 and was followed by minocycline in 1972. 5 Treatment with any tetracycline antibiotics for scrub typhus typically results in rapid and complete recovery. 6 Oral doxycycline is absorbed with a bioavailability of more than 80%, mainly in the stomach, duodenum, and jejunum. The oral form is more convenient to use than intravenous form but needs 2e3 hours to reach peak concentrations. 7e9 However, no clinical studies have compared the efficacy for the treatment of noncomplicated scrub typhus between oral doxycycline and intravenous minocycline. The present study was undertaken with this aim.
Methods
We performed a retrospective study at Buddhist Tzu Chi General Hospital (Taiwan), a 900-bed tertiary care university hospital and referral center. Hospitalized patients diagnosed with scrub typhus by serologic or molecular methods were enrolled. Patients complicated before tetracycline antibiotics therapy with acute renal or acute respiratory failure were excluded. The definition of acute respiratory failure was based on the sepsis-related organ failure assessment score criteria in which 3 or 4 [PaO 2 /FiO 2 (mmHg) < 200] is defined as severe organ failure. 10 Acute renal failure was defined as a rapid 3-fold increase in serum creatinine, decrease in glomerular filtration rate by 75%, or elevation of serum creatine to more than 4 mg/dL according the Risk, Injury, Failure, Loss, End stage classification of acute renal failure published by the Acute Dialysis Quality Initiative group in 2004. 11 Patients' medical data, including demographic characteristics, medical history, medications, laboratory data, and outcome were collected for analysis.
In our hospital, thermometers were used to check body temperature. Fever was defined as a body temperature more than 37.5 C. When a patient's body temperature returned to normal after fever, it was considered as defervescence. Time to defervescence was defined as the duration between the start of tetracycline antibiotic use and the resolution of fever. Calculation of time to defervescence was based on the timing when the vital signs were checked. In the ordinary ward of our hospital, the vital signs were checked every 8, 6, or 4 hours. Fever could be detected before the moment considered as the timing of defervescence and not detected after that moment. When the patient became defervescence after use of tetracycline antibiotics, we considered a response to the antibiotics had occurred.
Orientia tsutsugamushi serologic testing was performed for the presence of IgM and IgG specific antibodies by use of an indirect immunofluorescence assay. 12 The O tsutsugamushi antigens (Gilliam, Karp, and Kato strains) used were cultured in L cells. 13 IgM and IgG titers were determined in acute-and convalescent-phase sera serially diluted 2-fold in phosphate-buffered saline (PBS) from an initial 1:40 dilution. The slides were rinsed and washed twice in PBS (pH 7.4)-containing 0.05% Tween 20 (PBST) for 10 minutes. Fluorescein-conjugated goat anti-human IgM and IgG (Zymed, SanFrancisco, CA, USA) was used at the appropriate dilutions as the secondary antibody. After incubation for 30 minutes, the slides were rinsed and washed twice with PBST. The slides were mounted with mounting fluid (Chemicon, San Diego, CA, USA) under coverslips and observed using an ultraviolet epifluorescence microscope (Nikon, Tokyo, Japan). Sera found positive (IgM > 1:80 or a 4-fold increase in IgG titer in convalescent phase) were titrated to the endpoint.
Peripheral blood mononuclear cells were extracted from heparinized human blood samples by Ficoll/Hypaque density-gradient centrifugation. The genomic DNA of O tsutsugamushi was extracted by using the QIAamp Blood Mini Kit (QIAGEN, Valencia, CA, USA) following the manufacturer's protocols. O tsutsugamushi infection was diagnosed if the tested specimen was positive for the gene encoding the 56-kDa protein by nested polymerase chain reaction (PCR).
14 Target DNA was amplified in a mixture (total volume, 50 mL) containing 1.5 mM MgCl 2 , 50 mM KCl, 10 mM Tris-HCl (pH 8.3), 0.001% gelatin, 100 mM dNTPs, 0.2 mM primers, 1.25 U of FastStar Taq polymerase (Roche Diagnostics, Mannheim, Germany) and 5 mL of template DNA. The reaction was performed in 40 cycles of 94 C for 30 seconds, 57 C for 30 seconds, and 72 C for 60 seconds in a PTC-100 thermal cycler (MJ Research, Waltham, MA, USA). The final cycle was followed by an extension step at 72 C for 10 minutes. The size of the PCR-amplified products was determined under ultraviolet light following ethidium bromide staining. SPSS 11.5 for MS Windows (SPSS Inc., Chicago, IL, USA) software was used for the statistical analysis. Pearson's Chi-squared or Fisher's exact test was used to examine nominal data and unpaired Student's t test was used for continuous data. All tests were two-sided and a p value of 0.05 or less was considered significant. Time to defervescence was compared by Kaplan-Meier survival methods.
Results
Diagnosis of scrub typhus was confirmed by serology or molecular methods from August 2001 to July 2007 in 62 patients treated by tetracycline antibiotics. Of these, one patient received minocycline and levofloxacin simultaneously, and seven patients received oral minocycline. They were excluded from this study. Seven of the remaining 54 patients had acute renal or acute respiratory failure before usage of tetracycline antibiotics and were excluded. The remaining 47 patients were included for this study. Twentyfive cases received intravenous minocycline (Lederle parenterals, Carolina, USA) and 22 cases received oral doxycycline (China Chemical & Pharmaceutical, Taipei, Taiwan). In the 25 patients receiving intravenous minocycline, 16 patients were diagnosed with scrub typhus by the molecular method, 3 by the serologic method, and 6 by both methods. In the other group, 12 patients were diagnosed with scrub typhus by the molecular method, 7 by the serologic method, and 3 by both methods. The dosage of intravenous minocycline or oral doxycycline was 100 mg every 12 hours. There were no statistically significant difference between both groups in demographic, clinical, and laboratory data ( Table 1) .
Both antibiotic regimens were highly effective for scrub typhus. One patient did not respond to intravenous minocycline and two patients did not respond to oral doxycycline. They all responded to levofloxacin. The response rate was more than 90% in both groups and there was no statistically significant difference between two groups (96% for minocycline vs. 91% for doxycycline; p Z 0.909). In the intravenous minocycline-treated group, the mean time to defervescence was 30.7 hours (range 4e124 hours). The time in the oral doxycycline-treated group was 32.4 hours (range 4e144 hours). Kaplan-Meier curves with a log-rank test for the time to defervescence showed no statistically significant difference between both groups (p Z 0.860) (Fig. 1) . Nearly all patients (93.6%) became afebrile within 72 hours after use of tetracycline antibiotics. Acute Physiology and Chronic Health Evaluation (APACHE) II score, duration of symptoms before use of tetracycline antibiotics, timing to start tetracycline antibiotics after admission, and diabetes mellitus were considered as possible confounding factors affecting time to defervescence. These factors were checked by Cox regression models (Table 2) . APACHE II score was the most important factor to affect the time to defervescence (hazard ratio 0.868; p Z 0.016).
Because nearly all patients became afebrile within 72 hours after use of appropriate antibiotics, more than 7-day hospitalization for scrub typhus was considered as prolonged hospitalization. There were 36 patients with hospitalization for 7 or less days and 11 patients with hospitalization for more than 7 days. Timing to start tetracycline antibiotics after admission was the most important factor for prolonged hospitalization in the patients with noncomplicated scrub typhus (1.3 AE 0.5 days vs. 4.4 AE 2.3 days, p < 0.001) ( Table 3) . 
Discussion
In vitro, O tsutsugamushi is susceptible to doxycycline and minocycline. 15 Presently, although intravenous minocycline required less time to achieve peak concentration, the response rate and the time to defervescence in patients with noncomplicated scrub typhus treated by intravenous minocycline were not different from patients treated with oral doxycycline. The reported minimum inhibitory concentration of doxycycline is 0.15e0.31 mg/mL, 15, 16 which is much lower than the peak level of 100 mg oral doxycycline (1.7 mg/mL). Oral doxycycline is convenient to use and does not pose a risk for complications caused by insertion of a venous catheter. In addition, oral doxycycline is much cheaper than intravenous minocycline. Except when a patient is unable to take oral medicine, intravenous minocycline is not superior to oral doxycycline for noncomplicated scrub typhus.
APACHE II score is considered as an index of severity of infectious illness. Higher APACHE II score has been linked to higher mortality for scrub typhus in some studies. 17, 18 Longer time to defervescence was found in a study in which patients complicated with other conditions were included. 19 In our study, patients having mild illness scrub typhus were included. Most of them had neither an underlying disease nor high APACHE II scores. Although the patients had noncomplicated scrub typhus, the level of APACHE II score reflected the time to defervescence.
Prolonged hospitalization is associated with timing of tetracycline antibiotic therapy after admission. Because nearly all cases responding to oral doxycycline or intravenous minocycline became afebrile within 3 days, it was reasonable to suppose that delayed initiation of tetracycline antibiotics after admission could prolong hospitalization. In another study, patients with rickettsioses had delayed defervescence despite doxycycline treatment when they had jaundice, absence of headache, or relative bradycardia. 20 Jaundice was not evident in the present set of patients. Relative bradycardia was not proven to be related to prolonged hospitalization in our study, which might be attributable to the occurrence of mild scrub typhus in our patients. Some patients without headache did not have delayed defervescence or prolonged hospitalization in our study. Headache is an important clue to diagnose scrub typhus and absence of headache may delay correct diagnosis. But eastern Taiwan (where our hospital is located) is an endemic area of scrub typhus. Accordingly, scrub typhus is the first differential diagnosis for patients with fever of unknown cause. Treatment with tetracycline antibiotics or quinolones is typically used in febrile patients with or without headache. Therefore, delayed defervescence or prolonged hospitalization was not noted in our patients without headache.
In a prior study, a longer duration between disease onset and tetracycline treatment was not related to delayed defervescence, 20 as was noted in our study that included patients with noncomplicated scrub typhus. However, delaying adequate treatment for scrub typhus has been associated with severe complications, including acute respiratory failure or acute renal failure, which prolong hospitalization. 17 In our study, patients with severe complications of scrub typhus had been excluded. Delayed defervescence may not occur in patients with noncomplicated scrub typhus. In addition, information concerning the duration between disease onset to treatment was collected from the declaration of the patients or their family members. It is likely that the degree of illness severity varied individually, and the recall information did not reflect the correct duration of illness. Factors other than duration of illness probably will be associated with the severity of disease. Because of the retrospective design of this study, we did not control all confounding variables to affect the time to defervescence. We did not have data concerning pathogen strains and could not control the criteria for selection of therapeutic regimens. Previous reports showed a noteworthy proportion of patients with probable coinfections, 21 ,22 which were not presently ascertained. Because the moment when the patient's vital sign was checked was selected for the calculation of the time to defervescence, different intervals used in checking vital signs may have resulted in an error. In addition, the number of patients was small, limiting the interpretative power of the results.
Despite these limitations, the present study does provide information that oral doxycycline is not inferior to intravenous minocycline for the treatment of noncomplicated scrub typhus. Oral doxycycline is cheaper and more convenient to use and lacks the risk for complications caused by insertion of a venous catheter. Thus, oral doxycycline should be considered as the initial treatment for noncomplicated scrub typhus.
